HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rutong Yu Selected Research

Angiopep-2

12/2023The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma.
11/2020Hypoxia-Responsive Lipid-Polymer Nanoparticle-Combined Imaging-Guided Surgery and Multitherapy Strategies for Glioma.
1/2020Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
12/2019Angiopep-2 Modified Cationic Lipid-Poly-Lactic-Co-Glycolic Acid Delivery Temozolomide and DNA Repair Inhibitor Dbait to Achieve Synergetic Chemo-Radiotherapy Against Glioma.
11/2019Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.
9/2019Hypoxic Radiosensitizer-Lipid Coated Gold Nanoparticles Enhance the Effects of Radiation Therapy on Tumor Growth.
11/2018Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rutong Yu Research Topics

Disease

85Glioma (Gliomas)
04/2024 - 05/2012
64Neoplasms (Cancer)
04/2024 - 08/2009
18Glioblastoma (Glioblastoma Multiforme)
04/2024 - 05/2013
6Hypoxia (Hypoxemia)
11/2020 - 08/2009
4Carcinogenesis
01/2017 - 04/2014
3Brain Neoplasms (Brain Tumor)
12/2023 - 05/2019
2Neoplasm Metastasis (Metastasis)
11/2023 - 01/2013
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 01/2021
2Mental Disorders (Mental Disorder)
01/2022 - 01/2016
2Infections
01/2022 - 09/2020
2Inflammation (Inflammations)
01/2021 - 01/2020
1Breast Neoplasms (Breast Cancer)
11/2023
1Colorectal Neoplasms (Colorectal Cancer)
11/2023
1Hepatocellular Carcinoma (Hepatoma)
11/2023
1Body Weight (Weight, Body)
06/2023
1Otitis Media
01/2022

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
11/2023 - 10/2012
13Small Interfering RNA (siRNA)IBA
12/2023 - 04/2014
11CateninsIBA
07/2023 - 04/2014
11Phosphotransferases (Kinase)IBA
12/2022 - 10/2012
10Temozolomide (Temodar)FDA LinkGeneric
04/2024 - 10/2014
8Messenger RNA (mRNA)IBA
11/2022 - 10/2012
8PhosphoproteinsIBA
11/2019 - 04/2013
7Angiopep-2IBA
12/2023 - 11/2018
7LipidsIBA
01/2022 - 01/2018
6HydrogelsIBA
07/2021 - 01/2020
5Cadherins (E-Cadherin)IBA
02/2021 - 05/2013
4Therapeutic UsesIBA
12/2023 - 10/2018
4EnzymesIBA
01/2022 - 01/2020
4Matrix Metalloproteinases (MMPs)IBA
07/2021 - 01/2020
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 03/2016
3Endoplasmic Reticulum Chaperone BiPIBA
03/2024 - 01/2021
3SincalideFDA Link
06/2023 - 01/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2023 - 06/2017
3MicellesIBA
09/2020 - 10/2018
3Gefitinib (Iressa)FDA Link
02/2020 - 07/2019
3Radiation-Sensitizing AgentsIBA
09/2019 - 01/2018
3Liposomes (Liposome)IBA
11/2018 - 01/2017
3Protein Kinases (Protein Kinase)IBA
01/2018 - 10/2012
3Ligases (Synthetase)IBA
05/2017 - 03/2015
3UbiquitinIBA
05/2017 - 03/2015
3plumbaginIBA
07/2015 - 01/2014
2NanocapsulesIBA
04/2024 - 03/2023
2Glutathione (Reduced Glutathione)IBA
04/2024 - 10/2018
2osimertinibIBA
12/2023 - 05/2019
2Amino AcidsFDA Link
03/2023 - 03/2016
2MethyltransferasesIBA
11/2022 - 09/2020
2Tyrosine Kinase InhibitorsIBA
08/2022 - 11/2019
2TAK-243IBA
03/2022 - 01/2021
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 02/2015
2Chloroquine (Aralen)FDA LinkGeneric
03/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2014
2PolymersIBA
11/2020 - 09/2020
2NitroimidazolesIBA
11/2020 - 10/2018
2Oncogene Proteins (Oncogene Protein)IBA
11/2020 - 01/2020
2RNA (Ribonucleic Acid)IBA
08/2020 - 08/2009
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2020 - 10/2016
2Polylactic Acid-Polyglycolic Acid CopolymerIBA
12/2019 - 11/2019
2Epidermal Growth Factor (EGF)IBA
11/2019 - 01/2017
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2019 - 05/2019
2Protein Isoforms (Isoforms)IBA
01/2019 - 01/2016
2Cyclin D1IBA
01/2018 - 08/2014
2ProdrugsIBA
06/2017 - 01/2017
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
05/2017 - 01/2017
2Carrier Proteins (Binding Protein)IBA
01/2017 - 03/2016
2Ribosomal Proteins (Ribosomal Protein)IBA
01/2017 - 11/2016
2Monomeric GTP-Binding ProteinsIBA
01/2017 - 04/2013
2Tyrosine (L-Tyrosine)FDA Link
01/2015 - 10/2012
2geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA
05/2013 - 01/2013
1MethacrylatesIBA
04/2024
1Apolipoproteins E (ApoE)IBA
04/2024
1DisulfidesIBA
04/2024
1Chemokine CCL3IBA
03/2024
1Hormones (Hormone)IBA
03/2024
1CytokinesIBA
03/2024
1GDC-0084IBA
12/2023
1Drug CombinationsIBA
12/2023
1visininIBA
11/2023
1Glucose (Dextrose)FDA LinkGeneric
11/2023
1Long Noncoding RNAIBA
11/2023
1Dopamine (Intropin)FDA LinkGeneric
07/2023
1Blood Glucose (Blood Sugar)IBA
06/2023
1Sitagliptin Phosphate (Januvia)FDA Link
06/2023
1Dipeptidyl-Peptidase IV InhibitorsIBA
06/2023
1Fatty Acids (Saturated Fatty Acids)IBA
03/2023
1Proto-Oncogene Proteins c-fynIBA
12/2022
1N-methyladenosineIBA
11/2022
13- (4- dimethylaminobenzylidene)- 1,3- dihydroindol- 2- oneIBA
08/2022
1CalciumIBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
01/2022
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Methionine (L-Methionine)FDA Link
01/2022
1poly(propylene sulfide)IBA
01/2022

Therapy/Procedure

29Therapeutics
03/2024 - 04/2014
12Radiotherapy
01/2022 - 01/2017
10Drug Therapy (Chemotherapy)
04/2024 - 10/2014
5Injections
07/2021 - 01/2020
2Chemoradiotherapy
10/2018 - 01/2017
1Immunotherapy
03/2024